Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers A > Headlines for Amneal Pharmaceuticals, LLC > News item |
S&P affirms Amneal
S&P said it affirmed its BB- corporate credit rating on Amneal Pharmaceuticals LLC.
The outlook is negative.
The agency said the affirmation follows the announcement of Amneal's all-stock merger with Impax Laboratories.
“The transaction improves the company's scale and diversity, adding specialty drugs to the business. The merger will make the combined entity the fifth-largest generic company, and we believe the increase in scale is a positive because it improves the company's bargaining position with buyers,” S&P said in a news release.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.